Bone Biologics Corporatio... (BBLG)
0.83
-0.06 (-6.61%)
At close: Mar 03, 2025, 3:59 PM
0.80
-3.94%
After-hours: Mar 03, 2025, 05:28 PM EST
Bone Biologics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
Cash & Equivalents | 3.33M | 3.03M | 7.54M | 6.68M | n/a | 24.14K | 955.37K | 690.28K | 620.38K | 1.12M | 2.66M | 1.54K | 2.37 | n/a | n/a | -39.77K | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | -579.91K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 983.86K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 536.24K | 711.19K | 377.01K | n/a | n/a | 6.68K | 85.29K | 105.23K | 80.52K | 425.93K | 1.07M | 85.77K | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 3.86M | 3.74M | 8.5M | 6.68M | n/a | 30.83K | 1.04M | 795.51K | 972.84K | 2.07M | 3.81M | 87.31K | 2.37 | n/a | n/a | -39.77K | n/a |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | 50.00 | 146.00 | 242.00 | 5.8K | 11.62K | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | 50.00 | 146.00 | 242.00 | 5.8K | 11.62K | n/a | n/a | n/a | n/a | n/a | n/a |
Total Assets | 3.86M | 3.74M | 8.5M | 6.68M | n/a | 30.83K | 1.04M | 795.66K | 973.09K | 2.08M | 3.82M | 87.31K | 2.37 | n/a | n/a | -39.77K | n/a |
Account Payables | n/a | 360.66K | 104.79K | 99.91K | 465.4K | 42.88K | 125.2K | 216.9K | 226.52K | 186.81K | 119.78K | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | 783.67K | n/a | n/a | n/a | n/a | n/a | 75.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | 11.72M | n/a | 9M | n/a | 1.2M | n/a | 3.66M | 4.13M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 377.71K | 470.74K | 2.44M | n/a | 1.5M | 535.57K | 513.68K | 744.89K | 75.3K | 1.96M | 95.61K | 1.57M | 4.68K | n/a | n/a | n/a | n/a |
Total Current Liabilities | 377.71K | 831.4K | 2.55M | 99.91K | 13.69M | 578.45K | 9.64M | 961.79K | 3.32M | 2.15M | 3.87M | 5.7M | 4.68K | n/a | n/a | n/a | n/a |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 11.32M | n/a | 8.23M | 7.56M | 5.08M | 3.65M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | 888.46 | n/a | n/a | 11.32M | n/a | 8.23M | 6.28M | 5.62M | 3.65M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Liabilities | 377.71K | 831.4K | 2.55M | 99.91K | 13.69M | 11.9M | 9.64M | 9.19M | 9.61M | 7.76M | 7.52M | 5.7M | 4.68K | n/a | n/a | n/a | n/a |
Total Debt | n/a | n/a | n/a | n/a | 11.72M | 11.32M | 9M | 8.23M | 7.48M | 5.62M | 7.3M | 4.13M | n/a | n/a | n/a | n/a | n/a |
Common Stock | 2.95K | 534.00 | 15.3K | 10.35K | 30.68K | 30.68K | 26.45K | 43.28K | 38.83K | 32.21K | 24.27K | 10.93K | 10.93 | n/a | n/a | n/a | n/a |
Retained Earnings | -85.02M | -80.91M | -71.96M | -70.48M | -68.86M | -67.04M | -63.62M | -59.19M | -46.94M | -25.91M | -12.04M | -7.61M | -6.53K | n/a | n/a | n/a | n/a |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -357 | -261 | -3.98K | -280 | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 3.48M | 2.91M | 5.95M | 6.58M | -13.69M | -11.87M | -8.6M | -8.4M | -8.63M | -5.68M | -3.7M | -5.61M | -4.68K | n/a | n/a | n/a | n/a |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |